Skip to content
Search

Latest Stories

GPhC publishes new reports on racism and other inequalities in pharmacy

GPhC publishes new reports on racism and other inequalities in pharmacy

Racism and language barriers are “not purely a pharmacy problem, nor a health problem”, but a “much broader” system problem, says GPhC chair, Gisela Abbam.

The General Pharmaceutical Council (GPhC) has published new reports on racism and other inequalities in pharmacy, following a series of virtual equality roundtables.


This council organised its second equality roundtable on 18 September 2023, focussing on the topic of ‘Language Barriers and Health Inequalities’, and a follow-up roundtable on 'Racism in Pharmacy: Accountability Counts' on 10 October 2023.

A wide range of pharmacy-related organisations, patient groups, equality groups, providers of translation services and software, individual pharmacists, pharmacy technicians and wider teams from different sectors and settings attended the events.

GPhC chair, Gisela Abbam thanked speakers and attendees for listening and contributing to the important discussions around racism and language barriers, which she said are “not purely a pharmacy problem, nor a health problem”, but a “much broader” system problem.

“It is important we acknowledge that, and do what we can to tackle racism and barriers wherever we find them,” she added.

The GPhC noted that the discussions held during the roundtables will play a crucial role in shaping their regulatory work.

During the ‘Racism in Pharmacy’ session, Abbam highlighted the important link between racism and mental health, emphasising that the issue needs to be tackled together and in a sustained way.

She also cited the results of the first Pharmacy Workforce Race Equality Scheme published by NHS England which revealed that pharmacy professionals from Black, Asian and minority ethnic backgrounds experience more harassment and poorer progression in the workplace than their white counterparts.

GPhC chief executive, Duncan Rudkin, reiterated the Council’s commitment to address discrimination within pharmacy and support pharmacy teams to provide person-centred and inclusive care through its Equality, Diversity and Inclusion (EDI) Strategy.

Opening the ‘Language Barriers and Health Inequalities’ session, Abbam said that the GPhC is using all of its regulatory levers, as well as its wider influence to tackle discrimination and reduce health inequalities.

Rudkin ensured that the regulator sets standards that all pharmacy professionals must meet. “Our standards are designed to support professionals to provide person-centred care, including adapting their communication to meet the needs of different people and overcoming communication barriers,” he said.

Duncan mentioned that GPhC has also addressed language barriers in its new Equality Guidance for Registered Pharmacies. Published in 2023, the guidance highlighted the importance of accessible and inclusive services while setting out examples of how pharmacies can overcome language barriers.

More For You

Cargo plane unloading pharmaceuticals at US airport amid tariff concerns and stockpiling

Imports jumped in particular from Ireland, the top drug exporter to the US

Pic credit: iStock

Pharma imports to US surged in March as drugmakers look to avoid tariffs

Pharmaceutical imports to the US surged in March as drugmakers stocked up ahead of potential US tariffs on their products, which have historically been exempt from such fees.

Total imports of pharmaceutical products exceeded $50 billion in the month - the equivalent of 20 per cent of all pharmaceutical imports in 2024, according to data from a U.S. Commerce Department report on Tuesday.

Keep ReadingShow less
Scottish community pharmacist working in high street pharmacy with supportive environment

The PDA wants investment to reach those who deliver services to patients every day

Pic credit: iStock

Funding boost in Scotland “needs to work for not just pharmacy owners but pharmacists too”, says PDA

An increase in funding for community pharmacies in Scotland needs to lead to a greater focus on supporting pharmacists rather than “simply sustain business models”, according to the Pharmacy Defence Association (PDA).

Earlier this week, Community Pharmacy Scotland (CPS) accepted the Scottish government’s initial financial offer for the 2025/26 fiscal year, securing a guaranteed minimum reimbursement of £120 million for community pharmacies — up from £110 million from 2024/25.

Keep ReadingShow less
GP surgery upgrades for annual appointments

The surgeries will have additional space to “see more patients, boost productivity and improve patient care”

Pic credit: iStock

GP surgery upgrades to create 8.3 million more annual appointments

Over 1,000 GP surgeries will have their premises modernised to meet the needs of a further 8.3 million appointments each year, the government has announced.

Backed by a cash injection of over £102 million, the surgeries will have additional space to “see more patients, boost productivity and improve patient care”.

Keep ReadingShow less
Wales boosts funding for pharmacy-led UTI and sore throat test services

The sore throat test (STTT) and treat service will be widely available

Pic credit: istock

Welsh pharmacies receive funding boost for clinical services

Two key clinical services will be available in 99 per cent of community pharmacies across Wales after a boost in funding.

The sore throat test (STTT) and treat service and the urinary tract infection (UTI) service have both benefitted from contractual negotiations between the Welsh Government and Community Pharmacy Wales (CPW).

Keep ReadingShow less
Paul Bennett
Paul Bennett, CEO, Royal Pharmaceutical Society
Paul Bennett, CEO, Royal Pharmaceutical Society

Pharmacists need to take advantage of independent prescribing pathways, says Bennett

Independent prescribing will be a “significant point” in the history of community pharmacy, according to Royal Pharmaceutical Society chief executive Paul Bennett.

Last month, the RPS announced the launch of a comprehensive new prescribing development programme to support pharmacists across all stages of their prescribing careers.

Keep ReadingShow less